Accessibility: Skip TopNav
Tim Kelly, PhD
Tim Kelly joins AskBio to lead manufacturing of clinical- and commercial-scale AAV vectors to be used in gene therapy.
Format
JPEG
Quelle:
Asklepios BioPharmaceutical, Inc.
Downloads
Originalgröße
Groß
Mittel
Klein